Stockscreener 앱 받기
6.11
3.04%
0.18
전일 마감가:
$5.93
열려 있는:
$5.99
하루 거래량:
255.86K
Relative Volume:
0.86
시가총액:
$315.82M
수익:
-
순이익/손실:
$-19.90M
주가수익비율:
-11.53
EPS:
-0.53
순현금흐름:
$-19.80M
1주 성능:
+1.33%
1개월 성능:
+32.83%
6개월 성능:
-6.14%
1년 성능:
+53.52%
1일 변동 폭
$5.93
$6.18
1주일 범위
$5.68
$6.18
52주 변동 폭
$3.19
$6.8184
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
명칭
Diamedica Therapeutics Inc
전화
(763) 496-5454
주소
301 CARLSON PARKWAY, MINNEAPOLIS, MN
DMAC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
6.11 | 297.73M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-06-22 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-04-09 | 개시 | Oppenheimer | Outperform |
| 2021-02-17 | 개시 | ROTH Capital | Buy |
| 2020-10-30 | 개시 | Guggenheim | Buy |
| 2020-07-08 | 개시 | Maxim Group | Buy |
| 2019-04-30 | 개시 | Dougherty & Company | Buy |
| 2019-03-05 | 개시 | Lake Street | Buy |
모두보기
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
How high can DiaMedica Therapeutics Inc. stock goWeekly Trend Recap & Verified Short-Term Plans - Newser
Applying Elliott Wave Theory to DiaMedica Therapeutics Inc.2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
What’s the recovery path for long term holders of DiaMedica Therapeutics Inc.2025 Pullback Review & Risk Controlled Daily Plans - Newser
Full technical analysis of DiaMedica Therapeutics Inc. stockMarket Sentiment Report & Free Daily Entry Point Trade Alerts - Newser
Intraday pattern recognizer results for DiaMedica Therapeutics Inc.Weekly Market Outlook & Daily Profit Focused Screening - Newser
Pattern recognition hints at DiaMedica Therapeutics Inc. upsideTrade Risk Report & Weekly Top Gainers Trade List - Newser
Statistical indicators supporting DiaMedica Therapeutics Inc.’s strength2025 Technical Overview & Safe Capital Growth Tips - Newser
Technical signs of recovery in DiaMedica Therapeutics Inc.Market Performance Summary & Capital Protection Trading Alerts - Newser
DiaMedica Therapeutics (NASDAQ:DMAC) Receives Buy Rating from HC Wainwright - MarketBeat
Can momentum traders help lift DiaMedica Therapeutics Inc.July 2025 Breakouts & Smart Money Movement Tracker - Newser
DiaMedica Therapeutics Inc. stock chart pattern explainedQuarterly Profit Summary & Real-Time Buy Zone Alerts - Newser
Technical analysis overview for DiaMedica Therapeutics Inc. stockPortfolio Update Summary & Short-Term Trading Alerts - Newser
Can swing trading help recover from DiaMedica Therapeutics Inc. lossesWall Street Watch & Free Daily Entry Point Trade Alerts - Newser
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) insiders have had a fantastic week as stock increased 26%, and they haven't stopped buying - simplywall.st
Does DiaMedica Therapeutics (DMAC) Have the Potential to Rally 114.06% as Wall Street Analysts Expect? - Zacks Investment Research
Will DiaMedica Therapeutics Inc. see short term momentumNew Guidance & Breakout Confirmation Trade Signals - Newser
How to forecast DiaMedica Therapeutics Inc. trends using time seriesDollar Strength & Long-Term Growth Portfolio Plans - Newser
Is DiaMedica Therapeutics Inc. stock ready for a breakout2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
What makes DiaMedica Therapeutics Inc. stock price move sharplyPortfolio Value Summary & Stepwise Swing Trade Plans - Newser
Volume spikes in DiaMedica Therapeutics Inc. stock – what they meanGDP Growth & Stock Portfolio Risk Control - Newser
Can machine learning forecast DiaMedica Therapeutics Inc. recoveryTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - Newser
HC Wainwright Reaffirms Buy Rating for DiaMedica Therapeutics (NASDAQ:DMAC) - Defense World
Identifying reversal signals in DiaMedica Therapeutics Inc.Product Launch & Accurate Technical Buy Alerts - Newser
Intrinsic Value of DiaMedica Therapeutics Inc. Stock: Is It Undervalued or OvervaluedJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - Newser
Multi factor analysis applied to DiaMedica Therapeutics Inc.Insider Selling & Consistent Profit Alerts - Newser
Custom strategy builders for tracking DiaMedica Therapeutics Inc.Market Risk Summary & Community Consensus Picks - Newser
What indicators show strength in DiaMedica Therapeutics Inc.Analyst Downgrade & Risk Managed Investment Signals - Newser
What to expect from DiaMedica Therapeutics Inc. in the next 30 daysGap Up & Reliable Entry Point Trade Alerts - Newser
Is this a good reentry point in DiaMedica Therapeutics Inc.July 2025 Earnings & Reliable Entry Point Alerts - Newser
What’s the MACD signal for DiaMedica Therapeutics Inc.Entry Point & Weekly Watchlist for Hot Stocks - classian.co.kr
Chart based exit strategy for DiaMedica Therapeutics Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
DiaMedica Therapeutics Inc (DMAC) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2025 Earnings Call Transcript - Insider Monkey
DiaMedica advances DM199 programs with $60M cash runway and expanded clinical trials - MSN
DiaMedica Therapeutics Advances with Positive Trials and Funding - TipRanks
Diamedica Therapeutics Inc (DMAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Diamedica Therapeutics Inc 주식 (DMAC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Von Koch Thomas | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
2,857,142 |
9,999,997 |
8,383,577 |
| JACINTO RICHARD II | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
400,000 |
1,400,000 |
4,958,823 |
| Pilnik Richard D. | Director |
Apr 07 '25 |
Option Exercise |
2.11 |
24,000 |
50,640 |
312,995 |
| Giuffre Randall Michael | Director |
Feb 13 '25 |
Option Exercise |
2.56 |
17,000 |
43,570 |
392,412 |
0.94%
1.72%
자본화:
|
볼륨(24시간):